OTP-01

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NameOTP-01
Drug Alias NameOTP-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-PD-1Vascular endothelial growth factor receptor 2 modulators
TargetsProgrammed cell death protein 1Vascular endothelial growth factor receptor 2
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOttimo Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOttimo Pharma LtdAsimov IncBostonGene Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A